NextCure seeks Delaware court validation of 2025 1-for-12 reverse split ahead of Avere merger

NextCure filed a Section 205 petition seeking court validation of its July 2025 1-for-12 reverse stock split and related issued shares.Key Highlights:Original SEC Filing: NextCure, Inc. [ NXTC ] - 8-K - Sep. 25, 2026This is an AI-powered summary. It may contain inaccuracies. Consider verifying impo…